Sun Pharmaceutical Industries reports 8% rise in Q2 consolidated net profit

01 Nov 2022 Evaluate

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2022.

The company has reported rise of 49.93% in its net profit at Rs 1213.01 crore for Q2FY23 as compared to Rs 809.07 crore for the corresponding quarter previous year. Total income of the company increased by 20.32% to Rs 5,327.00 crore for the quarter under review as compared to Rs 4,427.42 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported rise of 8.21% in its net profit at Rs 2,260.17 crore for Q2FY23 as compared to Rs 2,088.73 crore for the same quarter in the previous year. Total income of the company increased by 12.07% to Rs 11037.50 crore for the quarter under review as compared to Rs 9,848.82 crore for the same quarter in the previous year.

Sun Pharma Inds. Share Price

1729.80 -7.05 (-0.41%)
13-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.80
Dr. Reddys Lab 1190.35
Cipla 1447.60
Zydus Lifesciences 900.25
Lupin 2176.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×